Tebentafusp
Showing 1 - 8 of 8
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
- Tebentafusp
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)
Not yet recruiting
- Advanced Melanoma
- Tebentafusp
- +2 more
- (no location specified)
Sep 19, 2022
Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)
Recruiting
- Melanoma (Skin)
- Melanoma, Uveal
- Tebentafusp
-
Oxford, United KingdomChurchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022
Uveal Melanoma Trial (Tebentafusp)
Available
- Uveal Melanoma
- Tebentafusp
- (no location specified)
Jan 5, 2022
Metastatic Uveal Melanoma Trial in Paris (Pembrolizumab 25 MG/1 ML Intravenous Solution)
Recruiting
- Metastatic Uveal Melanoma
- Pembrolizumab 25 MG/1 ML Intravenous Solution
-
Paris, FranceInstitut Curie
Aug 3, 2022
Uveal Melanoma Trial in Worldwide (IMCgp100)
Active, not recruiting
- Uveal Melanoma
-
La Jolla, California
- +25 more
Mar 10, 2022
Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)
Active, not recruiting
- Uveal Melanoma
- IMCgp100
- +3 more
-
Los Angeles, California
- +55 more
Mar 10, 2022